Endothelial cell activation in cutaneous vasculitis

Clinical and Experimental Dermatology

Volumn 21, Issue 1, 1996, Pages 28-32

  Jurd, K M ^a   Stephens, C J M ^b   Black, M M ^b   Hunt, B J ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; THROMBOPLASTIN; TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; CELL ACTIVITY; CLINICAL ARTICLE; DISEASE ACTIVITY; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; SKIN DISEASE; VASCULITIS;

ADULT; AGED; ENDOTHELIUM, VASCULAR; FEMALE; FIBRINOLYSIS; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATORS; SKIN DISEASES, VASCULAR; THROMBOMODULIN; THROMBOPLASTIN; VASCULITIS; VON WILLEBRAND FACTOR;

EID: 0029948451     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2230.1996.tb00007.x     Document Type: Article

References (25)

1. Kimberley RP. Immune complexes in the rheumatic diseases. Rheum Dis Clin North Am 1987; 13: 583-96.
2. Scott DGI, Blake Dr, Blann A. The role of lymphocytes and serum factors in vasculitic diseases. Ann Rheum Dis 1989; 43: 116-21.
3. Tann EM, Kinkel HG. An immunofluorescent study of skin lesions in systemic lupus erythematosus. Arthritis Rheum 1966; 9: 37-46.
4. Stern DM, Handley DA, Naworth PP. Endothelium in the regulation of coagulation. In: Simionescue N, Simionescue M, eds. Endothelial Cell Biology. New York: Plenum Press, 1988: 275-308.
5. Marcum JA, McKenny JB, Rosenburg RD. The acceleration of thrombin antithrombin complex formation in rat hind quarters via naturally occurring heparin-like molecules bound to the endothelium. J Clin Invest 1984; 74: 341-50.
6. Esmon CT. The roles of protein C and thrombomodulin in the regulation of blood coagulation. J Biol Chem 1989; 264: 4743-9.
7. Ruggeri ZM. von Willebrand factor and fibrinogen. Curr Opin Cell Biol 1993; 5: 898-906.
8. Lucore GL. Regulation of fibrinolysis by vascular endothelium. Coronary Artery Dis 1991; 2: 157-66.
9. Pober JS. Cytokine-mediated activation of vascular endothelium. Am J Pathol 1989; 133: 426-33.
10. Scarpati EM, Sadler JE. Regulation of endothelial cell coagulant properties. Modulation of tissue factor, plasminogen activator inhibitors and thrombomodulin by phorbol 12-myristate 13-acetate and tumour necrosis factor. J Biol Chem 1989; 264: 20705-13.
11. Koyama T, Nishida K, Ohdama S et al. Determination of plasma tissue factor antigen and its clinical significance. Br J Haematol 1994; 87: 343-7.
12. Nusinow SR, Federici AB, Zimmerman TS, Curd JG. Increased von Willebrand factor antigen in plasma of patients with vasculitis. Arthritis Rheum 1984; 27: 1405-10.
13. Federici AB, Fox RI, Esinoza LR, Zimmerman TS. Elevation of von Willebrand factor is independent of erythrocyte sedimentation rate and persists after glucocorticoid treatment in giant cell arteritis. Arthritis Rheum 1984; 27: 1046-50.
14. Woolf AD, Wakerley C, Wallington TB. Factor VIII related antigen in assessment of vasculitis. Ann Rheum Dis 1987; 46: 441-7.
15. Yazici H, Hekim N, Ozbakir F et al. von Willebrand factor in Behçets syndrome. J Rheumatol 1987; 14: 305-6.
16. Chajek T, Aronowski E and Izak G. Decreased fibrinolysis in Behçets disease. Thromb Diath Haemorrh 1973; 29: 610-18.
17. Sun NC, Conn DL, Schroeter AL, Kazmier FJ. Skin fibrinolytic activity in cutaneous and systemic vasculitis. Mayo Clin Proc 1976; 51: 216-22.
18. Jordan JM, Allen NB, Pizzo SV. Defective release of tissue plasminogen activator in systemic and cutaneous vasculitis. Am J Med 1987; 82: 397-400.
19. Pizzo SV, Murray JC, Gonias SL. Atrophie Blanche: a disorder associated with defective release of tissue plasminogen activator. Arch Pathol Lab Med 1986; 110: 517-19.
20. Francis RB, McGehee Jr WG, Feinstein DI. Endothelial-dependent fibrinolysis in subjects with the lupus anticoagulant and thrombosis. Throm Haemostas 1988; 59: 412-14.
21. Ishii H, Marjerus PW. Thrombomodulin is present in human plasma and urine. J Clin Invest 1985; 76: 2178-81.
22. Hergesell O, Andrassy K, Geberth S et al. Plasma thrombomodulin levels are dependent on renal function. Thromb Res 1993; 72: 455-8.
23. Iwashima Y, Sato T, Watanabe K et al. Elevation of plasma thrombomodulin levels in diabetic patients with early diabetic nephropathy. Diabetes 1990; 39: 983-8.
24. Amano K, Tateyama M, Inhab H et al. Fluctuations in plasma levels of thrombomodulin in patients with DIC. Thromb Haemostas 1992; 68: 404-6.
25. Moore KL, Esmon CT, Esmon NL. Tumor necrosis factor leads to the internalization and degradation of thrombomodulin from the surface of bovine aortic endothelial cells in culture. Blood 1989; 73: 159-63.